Sphingomonas paucimobilis bacteremia related to intravenous human immunoglobulin injections

Med Mal Infect. 2012 Jan;42(1):37-9. doi: 10.1016/j.medmal.2011.10.002. Epub 2011 Nov 8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Agammaglobulinemia / therapy
  • Anti-Bacterial Agents / therapeutic use
  • Bacteremia / drug therapy
  • Bacteremia / etiology*
  • Bacteremia / microbiology
  • Catheter-Related Infections / drug therapy
  • Catheter-Related Infections / microbiology*
  • Catheterization, Central Venous / adverse effects*
  • Cross Infection / drug therapy
  • Cross Infection / etiology*
  • Cross Infection / microbiology
  • Drug Contamination
  • Equipment Contamination
  • Female
  • Gram-Negative Bacterial Infections / drug therapy
  • Gram-Negative Bacterial Infections / etiology*
  • Gram-Negative Bacterial Infections / microbiology
  • Humans
  • Immunocompromised Host
  • Immunoglobulins, Intravenous / administration & dosage
  • Immunoglobulins, Intravenous / adverse effects*
  • Immunoglobulins, Intravenous / therapeutic use
  • Lymphoma, Follicular / complications
  • Lymphoma, Follicular / surgery
  • Male
  • Middle Aged
  • Multiple Myeloma / drug therapy
  • Neutropenia / chemically induced
  • Neutropenia / therapy
  • Postoperative Complications / therapy
  • Sphingomonas / isolation & purification*
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Immunoglobulins, Intravenous